Metastatic large-cell neuroendocrine prostate carcinoma: successful treatment with androgen deprivation therapy.
Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: arun.azad@bccancer.bc.ca.
Arun A
AA
Azad
Department of Pathology and Laboratory Medicine and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Edward C
EC
Jones
Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: kchi@bccancer.bc.ca.
Kim N
KN
Chi
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000188:drug therapy* / Q000556:secondary; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000726:Androgen Antagonists
Androgen deprivation therapy; Large cell; Large cell neuroendocrine carcinoma; Neuroendocrine carcinoma; Prostate carcinoma